ArticleDermatology reports2024
Exploring adult-onset actinic prurigo in Thailand.
Article in Dermatology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Isolated Actinic Prurigo Cheilitis in an Elderly Thai Female: An Atypical Presentation.Clinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Actinic prurigo (AP) is an uncommon photodermatosis. In European and Native American populations, AP is more common in young women and demonstrates clinical improvement or remission in adulthood. The clinical signs of AP differ in Asians because the disorder typically occurs in adults (adult-onset AP) and is clinically persistent. The objective of this study was to investigate the characteristics and outcomes of patients with AP in Thailand. A total of 15 cases with AP were evaluated. All of them were adult-onset AP (mean onset age of 45.5 years). Males predominated (66.7%). The majority of them manifested with papules on the face and upper extremities. Mucositis was present in 2 patients. Phototesting revealed that the minimal erythematous dose (MED) for UVA decreased in 3 subjects and the MED for both UVA and UVB decreased in other 3 patients. A photo-provocation test was performed on 9 patients with normal MED, and 5 of them showed positive UVA photo-provocation, while 4 showed positive UVA and UVB photop-rovocation. A systemic immunosuppressant was prescribed in 60% of patients. Median time for clinical improvement was 8.6 months. Complete clinical remission was found in only 3 patients. Adult-onset AP has different clinical features and responds differently to treatment, compared to classical AP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.